EP 2802577 B1 20170301 - TRIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
Title (en)
TRIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
Title (de)
TRIAZOLYLSUBSTITUIERTE PYRIDYLVERBINDUNGEN ALS KINASEINHIBITOREN
Title (fr)
COMPOSÉS PYRIDYLES À SUBSTITUTION TRIAZOLYLE UTILES COMME INHIBITEURS DE KINASES
Publication
Application
Priority
- US 201261586139 P 20120113
- US 2013021096 W 20130111
Abstract (en)
[origin: WO2013106614A1] Compounds having the following formula:(I) wherein:A is an optionally substiuted triazole, or a stereoisomer or a pharmaceutically-acceptable salt thereof, are useful as kinase modulators, including IRAK-4 modulation.
IPC 8 full level
C07D 413/04 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/498 (2006.01); A61K 31/5025 (2006.01); A61K 31/506 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01)
CPC (source: CN EP US)
A61P 29/00 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 413/04 (2013.01 - CN EP US); C07D 413/14 (2013.01 - CN EP US); C07D 417/04 (2013.01 - CN EP US); C07D 417/14 (2013.01 - CN EP US); C07D 471/04 (2013.01 - CN EP US); C07D 471/10 (2013.01 - CN EP US); C07D 487/04 (2013.01 - CN EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2013106614 A1 20130718; CN 104169275 A 20141126; CN 104169275 B 20170609; EP 2802577 A1 20141119; EP 2802577 B1 20170301; ES 2630705 T3 20170823; JP 2015503621 A 20150202; JP 6096807 B2 20170315; US 2015045347 A1 20150212; US 8987311 B2 20150324
DOCDB simple family (application)
US 2013021096 W 20130111; CN 201380013640 A 20130111; EP 13700829 A 20130111; ES 13700829 T 20130111; JP 2014552312 A 20130111; US 201314371281 A 20130111